Cargando…
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
BACKGROUND: Smad interacting protein-1 is a transcription factor that is implicated in transforming growth factor-β/bone morphogenetic protein signaling and a repressor of E-cadherin and human telomerase reverse transcriptase. It is also involved in epithelial-mesenchymal transition and tumorigenesi...
Autores principales: | Acun, Tolga, Oztas, Emin, Yagci, Tamer, Yakicier, Mustafa C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118200/ https://www.ncbi.nlm.nih.gov/pubmed/21645397 http://dx.doi.org/10.1186/1471-2407-11-223 |
Ejemplares similares
-
Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer
por: Chen, Mingquan, et al.
Publicado: (2011) -
Hypermethylation Leads to Bone Morphogenetic Protein 6 Downregulation in Hepatocellular Carcinoma
por: He, Yinghua, et al.
Publicado: (2014) -
Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma
por: Nawaz, Imran, et al.
Publicado: (2015) -
Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer
por: Cheng, Y Y, et al.
Publicado: (2008) -
Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)